CD274 and neoplasm: Traditional markers used to predict ICI response, including PD-L1 expression, tumor mutational burden (TMB), and microsatellite instability (MSI), each suffer from limited sensitivity, variable inter-lab reproducibility, and challenges with spatial and temporal heterogeneity.